0001753926-24-000372.txt : 20240223 0001753926-24-000372.hdr.sgml : 20240223 20240223171256 ACCESSION NUMBER: 0001753926-24-000372 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240221 FILED AS OF DATE: 20240223 DATE AS OF CHANGE: 20240223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Friedberg Ezra M CENTRAL INDEX KEY: 0001679440 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41964 FILM NUMBER: 24672545 MAIL ADDRESS: STREET 1: 1000 MARINA BOULEVARD STREET 2: SUITE 250 CITY: BRISBANE STATE: CA ZIP: 94005 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Chromocell Therapeutics Corp CENTRAL INDEX KEY: 0001919246 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 863335449 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 685 US HIGHWAY ONE CITY: NORTH BRUNSWICK STATE: NJ ZIP: 08902 BUSINESS PHONE: 9176446313 MAIL ADDRESS: STREET 1: 685 US HIGHWAY ONE CITY: NORTH BRUNSWICK STATE: NJ ZIP: 08902 4 1 ownership.xml X0508 4 2024-02-21 0 0001919246 Chromocell Therapeutics Corp CHRO 0001679440 Friedberg Ezra M C/O CHROMOCELL THERAPEUTICS CORPORATION 4400 ROUTE 9 SOUTH, SUITE 1000 FREEHOLD NJ 07728 1 0 0 0 0 Common Stock 2024-02-21 4 M 0 13649 4.8 A 513727 I Balmoral Financial Group LLC Common Stock 2024-02-21 4 M 0 6992 4.8 A 520719 I Balmoral Financial Group LLC Secured Convertible Promissory Note 4.80 2024-02-21 4 C 0 65513.61 D 2024-02-21 2024-02-29 Common Stock 13649 0 I Balmoral Financial Group LLC Secured Convertible Promissory Note 4.80 2024-02-21 4 C 0 33136.00 D 2024-02-21 2024-03-01 Common Stock 6992 0 I Balmoral Financial Group LLC The securities are held by Balmoral Financial Group LLC ("Balmoral"). The Reporting Person serves as a manager of Balmoral, which also manages a retirement account for the Reporting Person, and, accordingly, the Reporting Person may also be deemed to beneficially own the shares of common stock held by Balmoral (or managed by Balmoral, in respect of the retirement account). Represents $65,513.61 of outstanding principal and accrued and unpaid interest of this senior secured convertible promissory note, due February 29, 2024, which automatically converted into 13,649 shares of common stock of the Issuer at a conversion price of 80.0% of the offering price of the securities sold to the public in the Issuer's initial public offering. Represents $33,136.00 of outstanding principal and accrued and unpaid interest of this senior secured convertible promissory note, due March 1, 2024, which automatically converted into 6,992 shares of common stock of the Issuer at a conversion price of 80.0% of the offering price of the securities sold to the public in the Issuer's initial public offering, including an additional 88 shares of common stock issued as consideration for this senior secured convertible promissory note. /s/ Ezra Friedberg 2024-02-23